News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InflaRx Raises Financing to Develop a New Therapeutic Approach Against Sepsis


3/18/2008 12:01:20 PM

JENA, Germany--(BUSINESS WIRE)--InflaRx GmbH, announced today the closing of its seed financing led by Affentranger Associates alongside with bm-t beteiligungsmanagement thüringen gmbh. InflaRx’s mission is to develop new therapeutic approaches to prevent and treat sepsis. Created by Prof. Niels Riedemann and Prof Renfeng Guo, two worldwide recognized researchers in the field of inflammation and sepsis, InflaRx has already brought its leading development program targeting activation products of the complement system in an advanced pre-clinical stage.

Read at BioSpace.com

comments powered by Disqus
InflaRx
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES